Back to Directory
Last Updated: 06/06/2026
Arecor Therapeutics
Cambridge
Founded 2007
Proprietary formulation platform enhancing diabetes and cardiometabolic therapies
Arecor Therapeutics is a biopharmaceutical company developing enhanced formulations of existing therapeutic products for diabetes and cardiometabolic diseases.
Its proprietary formulation technology improves stability, concentration and delivery profiles for biologics and peptides, supporting both in-house programmes and partnered development with pharmaceutical and medtech companies.
One formulated product is on the market and generating royalties.
The lead proprietary pipeline includes an ultra-concentrated rapid-acting insulin and an oral GLP-1 programme for obesity and type 2 diabetes.